CLASS II Drug recall · Reported 29 May 2013 · FDA Enforcement Report
Lloyd Thyro-Tab 150 mg recalled by Lloyd Inc. of Iowa
Lloyd Inc. of Iowa is recalling Lloyd Thyro-Tab 150 mg, distributed nationwide in the US. The recall was initiated on 1 Apr 2013 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-442-2013
- FDA event ID
- 65154
- Recalling firm
- Lloyd Inc. of Iowa, Shenandoah, IA
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 1 Apr 2013
- FDA classified
- 21 May 2013
- Reported
- 29 May 2013
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Potency & Assay
Timeline
| 1 Apr 2013 | Recall initiated by company | |
| 21 May 2013 | Classified by FDA | +50 days |
| 29 May 2013 | Published in enforcement report | +8 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.
Product as listed by the FDA
Lloyd Thyro-Tab 0.150 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
Where it was distributed
The firm distributed the bulk product to Forest Laboratories, Inc, St. Louis, MO who repackaged the product into 100-tablet bottles and distribution was made to 75 customers Nationwide and Puerto Rico.
Questions about this recall
Is Lloyd Thyro-Tab 150 mg recalled?
Yes. Lloyd Inc. of Iowa recalled Lloyd Thyro-Tab 150 mg on 1 Apr 2013. The recall is Class II and its status is Terminated. Recall number D-442-2013.
Why was it recalled?
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.
Which lots are affected?
Lot #: HE27811, HD27811, Exp Apr-13; HC00512, Exp Jul-13; HD04112, HE06212, Exp Sep-13.
Where was it sold?
The firm distributed the bulk product to Forest Laboratories, Inc, St. Louis, MO who repackaged the product into 100-tablet bottles and distribution was made to 75 customers Nationwide and Puerto Rico.
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Lloyd Inc. of Iowa
All 36| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Lloyd Thyro-Tab 200 mg recalled by Lloyd Inc. of Iowa | Lloyd Inc. of Iowa | Potency & Assay | Nationwide |
| Drug | CLASS II | Levothroid (levothyroxine sodium tablets, USP), 175 mcg recalled | Lloyd Inc. of Iowa | Potency & Assay | Nationwide |
| Drug | CLASS II | Lloyd Thyro-Tab 175 mg recalled by Lloyd Inc. of Iowa | Lloyd Inc. of Iowa | Potency & Assay | Nationwide |
| Drug | CLASS II | Lloyd Thyro-Tab 137 mg recalled by Lloyd Inc. of Iowa | Lloyd Inc. of Iowa | Potency & Assay | Nationwide |
| Drug | CLASS II | Levothroid (levothyroxine sodium tablets, USP) , 125 mcg recalled | Lloyd Inc. of Iowa | Potency & Assay | Nationwide |